Molecular Data Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Molecular Data's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Trade Distributors Industry Growth | 23.4% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 30 Jun 2021 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Molecular Data makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 21 | 4,619 | -256 | 243 | 19 |
31 Mar 21 | 6,108 | -292 | 265 | 27 |
31 Dec 20 | 7,596 | -328 | 286 | 35 |
30 Sep 20 | 10,080 | -277 | 262 | 45 |
30 Jun 20 | 12,525 | -195 | 214 | 49 |
31 Mar 20 | 12,866 | -194 | 231 | 47 |
31 Dec 19 | 13,207 | -194 | 248 | 45 |
30 Sep 19 | 12,114 | -300 | 351 | 46 |
30 Jun 19 | 11,260 | -299 | 340 | 43 |
31 Mar 19 | 10,157 | -277 | 310 | 40 |
31 Dec 18 | 9,053 | -255 | 279 | 37 |
30 Sep 18 | 7,829 | -124 | 135 | 24 |
31 Dec 17 | 4,202 | -108 | 121 | 19 |
31 Dec 16 | 3,206 | -114 | 112 | 20 |
Quality Earnings: Insufficient data to determine if MKDT.Y has high quality earnings.
Growing Profit Margin: Insufficient data to determine if MKDT.Y's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MKDT.Y's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare MKDT.Y's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if MKDT.Y's earnings growth over the past year exceeded the Trade Distributors industry average.
Return on Equity
High ROE: MKDT.Y has a negative Return on Equity (0%), as it is currently unprofitable.